Latest News

Read the latest news from 23Strands, media releases, journal articles and company announcements.

Entries for 'future of medicine'

Research on Artificial Intelligence-Driven Biomedical Genomics
Research News

Research on Artificial Intelligence-Driven Biomedical Genomics

Our recent article delves into the profound impact of AI on precision medicine and genomics, elucidating its potential implications for the healthcare industry. From disease prevention strategies tailored to individual genetic profiles to the optimisation of treatment modalities, AI-driven solutions are heralding a change in thinking.

Women's Health Week 2023
Announcements

Women's Health Week 2023

During Women's Health Week 2023, we had the privilege of hosting Dr. Amandeep Hansra, who shared valuable insights into clinical study biases that have historically overlooked women's health.

23Strands x TRIAS Strategic Agreement
Announcements

23Strands x TRIAS Strategic Agreement

In exciting news, 23Strands and TRIAS have teamed up to advance genomics in healthcare. The recent signing of a memorandum of understanding (MOU) represents a significant step forward in the field of genomics.

Better Health Outcomes for All Australians – Medical Research Future Funding
Press Release

Better Health Outcomes for All Australians – Medical Research Future Funding

Sydney-based biotech start-up, 23Strands to play an integral and leading role in researching the benefit of genomic medicine to Indigenous Australians.
Leading this 5 year collaboration is Professor Alex Brown from the Australian National University who focussed on establishing the National Indigenous Genomics Network of research nodes to engage with Indigenous Australians in genetic research and health care in a culturally safe way.

Haemochromatosis Awareness Week
Cancer23

Haemochromatosis Awareness Week

23Strands merges AI with whole genomic sequencing to create personalized treatments for genetic diseases, including haemochromatosis. They conduct thorough gene expression analyses, pinpointing potential targets for precision drug therapy and assessing chemotherapy responses. Their primary goal is addressing genetic diseases through personalized medicine.

World Hypertension Day 2023
Cardio23

World Hypertension Day 2023

On this World Hypertension Day (17 May) 23Strands embraces the vision of a future in which people with genetic markers for hypertension and other cardiovascular diseases will be identified before suffering symptoms, damage, or illness, allowing for lifestyle adjustments to prevent disease.

23Strands in Support of White Shirt Day in the Fight against Ovarian Cancer
Cancer23

23Strands in Support of White Shirt Day in the Fight against Ovarian Cancer

23Strands is standing in solidarity in the fight against ovarian cancer. Ovarian cancer remains one of the most fatal cancers affecting women. Globally, a woman or girl who is diagnosed with ovarian cancer faces a 49% chance of surviving the next five years. Despite this, research in ovarian cancer persists to be disproportionately low in comparison to other fields of oncology.

Arc Linkage Program Team Spotlight
Press Release

Arc Linkage Program Team Spotlight

As part of a prestigious program to encourage research collaboration, 23Strands has secured funding in partnership with the University of Technology Sydney (UTS). The Australian Research Council’s Linkage Program (ARC LP) aims to encourage and extend cooperative approaches to research and encourages the transfer of skills, knowledge and ideas as a basis for securing commercial and other benefits of research.

Page 1 of 3
  • First
  • Previous
  • (1]
  •   
  • 2
  •   
  • 3
  •   
  • Next
  • Last